Wednesday 28 July 2021
Associate Professor Lianne Parkin and colleagues from the Pharmacoepidemiology Research Network have been awarded $1.2 million from the Health Research Council of New Zealand to investigate the use and safety of an anti-nausea drug during pregnancy.
Tuesday 8 June 2021
University of Otago research into what helps and hinders people with type 2 diabetes correctly taking, and continuing to take, metformin, features in today’s New Zealand Medical Journal.
Wednesday 19 May 2021
Almost half of New Zealand women who take antidepressants in the months before getting pregnant, stop during their pregnancy, a new University of Otago study shows.
Tuesday 9 February 2021
The Ngāi Tahu Māori Health Research Unit's Dr Karyn Maclennan is currently piloting a new, innovative and hands-on education programme targeted at tamariki.
Wednesday 27 January 2021
The use of two long-acting bronchodilator inhalers to treat chronic obstructive pulmonary disease (COPD) symptoms is associated with a higher risk of acute coronary syndrome (ACS, heart attack or unstable angina) than the use of just one long-acting bronchodilator according to recently published research by investigators from the Pharmacoepidemiology Research Network at the University of Otago.
Thursday 26 November 2020
More than half a million New Zealand adults are taking cholesterol-lowering medications, but a new University of Otago study reveals many are not taking them consistently.